Related Experiment Video

Updated: Dec 25, 2025

Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

6.9K

Targeting Histone Acetyltransferase MOZ/KAT6A as a New Avenue for Hematological Tumor Therapy

Chongchen Zhou1, Hai-Liang Zhu1, Yongtao Duan1

  • 1Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China.

Current Topics in Medicinal Chemistry
|April 4, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
09:20

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on: August 10, 2017

8.9K
Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays
11:17

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays

Published on: June 13, 2019

7.6K

Related Experiment Videos

Last Updated: Dec 25, 2025

Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

6.9K
Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
09:20

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on: August 10, 2017

8.9K
Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays
11:17

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays

Published on: June 13, 2019

7.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

Articles linked to this work by shared authors, journal, and citation graph.

A near-infrared fluorescent probe lights up protective carbon monoxide during inflammation in live systems.

Analytica chimica acta·2026

A BBB-permeable β3-AR probe enables redox imaging, natural inhibitors discovery, and therapeutic monitoring in glioblastoma.

Science advances·2026

Synthesis and evaluation of 5-phenoxylmethyl-1,3,4-oxadiazol-2-ones/oxadiazole-2-thiones as potent urease inhibitors.

Bioorganic & medicinal chemistry·2026

Visualization of Stress-Induced Dynamic Ethylene in AOX1A Transgenic Using a Fluorescent Lifetime Probe.

Analytical chemistry·2026

Ultra-large stokes shift probe enables SIM super-resolution tracking of lysosomal acidification impairment in Aβ trafficking dysregulation during Alzheimer's disease.

Biosensors & bioelectronics·2025

Design, synthesis, and biological evaluation of 2-(benzylthio)-5-(indol-3-yl)-1,3,4-oxadiazole derivatives as tubulin polymerization inhibitors with potential anti-cancer effects.

European journal of medicinal chemistry·2025

Antibacterial and Antibiofilm Properties of (E,E)-Farnesol Diamine-Derivatives: Potential New Agents Against Methicillin-Resistant Staphylococcus aureus and Escherichia coli.

Current topics in medicinal chemistry·2026

A New Flavonol Glucoside from Turpinia montana Kurz and Its Synergistic NO Inhibitory Activity with a Triterpene Glucoside.

Current topics in medicinal chemistry·2026

Nanochitosan as a Multifunctional Platform for HIV Prevention and Therapy: From Mucosal Defense to Targeted Drug Delivery and Mathematical Modeling.

Current topics in medicinal chemistry·2026

Advances in Herbal Nanomedicine for Cardiovascular Therapeutics.

Current topics in medicinal chemistry·2026

Targeting Autoimmunity in Type 1 Diabetes: Emerging Immunomodulatory Therapies.

Current topics in medicinal chemistry·2026

Epigenetic Modifiers and Synthetic Lethality in Cancer Therapy: Emerging Targets Beyond Traditional Approaches.

Current topics in medicinal chemistry·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us